New diabetes clinical trial: A Study of Orforglipron (LY3502970) in Adult Participants with Obesity or Overweight

Published on: February 12, 2025 at 11:00PM
Conditions: Obesity; Overweight
Interventions: Drug: Orforglipron; Drug: Placebo
Sponsors: Eli Lilly and Company
Not yet recruiting
https://ift.tt/fwa1Ch7